文献速递神经肿瘤

基因表达综合数据库的生物信息学分析将TAF7/CCNB1、TAF7/CCNA2和GTF2E2/CDC20通路与胶质母细胞瘤的发生发展及预后相关联

Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
PubMed 文献 · World Neurosurg · 2020-03-05

本研究通过生物信息学分析基因表达综合数据库(GEO)中4个数据集(GSE4290、GSE50161、GSE116520、GSE90598),识别胶质母细胞瘤与正常脑组织间的差异表达基因,并利用癌症基因组图谱等数据验证核心基因的转录和翻译水平及预后价值,发现TAF7/CCNB1、TAF7/CCNA2和GTF2E2/CDC20信号轴与胶质母细胞瘤发病机制和不良预后相关。

要点

  • 共识别473个差异表达基因,其中182个上调、291个下调。
  • 核心基因CCNB1、CDC20、BUB1、CCNA2在胶质母细胞瘤中高表达且与较差的总生存期相关。
  • TAF7可上调CCNB1和CCNA2表达,GTF2E2可上调CDC20表达。

核心结论

  • 胶质母细胞瘤中存在多个差异表达基因,其核心基因的异常表达与胶质母细胞瘤发病机制和不良预后相关,尤其是TAF7/CCNB1、TAF7/CCNA2和GTF2E2/CDC20信号轴。

研究设计与样本

  • 生物信息学分析研究,检索基因表达综合数据库(GEO)并获取4个数据集(GSE4290、GSE50161、GSE116520和GSE90598),使用limma和RobustRankAggreg包分析胶质母细胞瘤与正常脑组织间的差异表达基因。

主要发现

  • 共识别473个差异表达基因(182个上调,291个下调)。
  • 核心基因(包括CCNB1、CDC20、CCNB2、BUB1和CCNA2)在模块1中显示并富集于细胞周期或p53信号通路。
  • 胶质母细胞瘤患者中高表达的CCNB1、CDC20、BUB1和CCNA2与较差的总生存期相关。
  • TAF7可上调胶质母细胞瘤中CCNB1和CCNA2的表达,GTF2E2可上调CDC20的表达。

关键数值与推荐

  • 差异表达基因筛选及核心基因识别使用limma和RobustRankAggreg包分析GEO数据集。
  • 核心基因的转录和翻译水平验证使用癌症基因组图谱(TCGA)、基因型-组织表达(GTEx)和人类蛋白质图谱(HPA)数据。
  • 预后价值分析使用中国胶质瘤基因组图谱(CGGA)数据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study bioinformatically analyzed aberrant genes and pathways for associations with glioblastoma development and prognosis. METHODS: The Gene Expression Omnibus (GEO) database was searched and 4 GEO datasets (GSE4290, GSE50161, GSE116520, and GSE90598) were retrieved for limma and RobustRankAggreg package analyses of differentially expressed genes (DEGs) between glioblastoma and normal brain tissues. Functional enrichment analysis was conducted for the main biological functions of these DEGs, whereas the hub genes were identified using the protein-protein interaction network and confirmed for transcriptional and translational levels using the Cancer Genome Atlas, the Genotype-Tissue Expression, and the Human Protein Atlas data. The prognostic values of these hub genes were analyzed using the Chinese Glioma Genome Atlas. Their transcriptional factor regulation network was constructed to assess the roles in glioblastoma development and progression. RESULTS: A total of 473 DEGs (182 upregulated and 291 downregulated) were identified and the hub genes (including CCNB1, CDC20, CCNB2, BUB1, and CCNA2) were shown in module 1 and enriched in the cell cycle or p53 signaling pathway. The highly expressed CCNB1, CDC20, BUB1, and CCNA2 in patients with glioblastoma were associated with poor overall survival, whereas TAF7 could upregulate expression of CCNB1 and CCNA2 and GTF2E2 could upregulate CDC20 expression in glioblastoma. CONCLUSIONS: This study showed several DEGs in glioblastoma, and aberrant expression of their hub genes was associated with glioblastoma pathogenesis and poor prognosis, especially the signaling axes of TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang L, Zeng W, Sun H, et al. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. World Neurosurg. 2020. PMID: 32147549. doi:10.1016/j.wneu.2020.02.159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。